- Home
- GTBP vs STRR Comparison
GTBP vs STRR Comparison
Compare GTBP & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- STRR
- Stock Information
- Founded
- GTBP 1965
- STRR 1985
- Country
- GTBP United States
- STRR United States
- Employees
- GTBP N/A
- STRR N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GTBP Health Care
- STRR Health Care
- Exchange
- GTBP Nasdaq
- STRR Nasdaq
- Market Cap
- GTBP 5.5M
- STRR 6.3M
- IPO Year
- GTBP N/A
- STRR N/A
- Fundamental
- Price
- GTBP $3.48
- STRR $1.93
- Analyst Decision
- GTBP Strong Buy
- STRR Strong Buy
- Analyst Count
- GTBP 1
- STRR 1
- Target Price
- GTBP $11.00
- STRR $5.00
- AVG Volume (30 Days)
- GTBP 75.0K
- STRR 24.8K
- Earning Date
- GTBP 08-13-2025
- STRR 08-12-2025
- Dividend Yield
- GTBP N/A
- STRR N/A
- EPS Growth
- GTBP N/A
- STRR N/A
- EPS
- GTBP N/A
- STRR N/A
- Revenue
- GTBP N/A
- STRR $57,165,000.00
- Revenue This Year
- GTBP N/A
- STRR $33.64
- Revenue Next Year
- GTBP N/A
- STRR $22.87
- P/E Ratio
- GTBP N/A
- STRR N/A
- Revenue Growth
- GTBP N/A
- STRR 34.33
- 52 Week Low
- GTBP $1.72
- STRR $1.72
- 52 Week High
- GTBP $4.10
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- GTBP 76.91
- STRR 41.41
- Support Level
- GTBP $2.75
- STRR $1.95
- Resistance Level
- GTBP $3.28
- STRR $2.11
- Average True Range (ATR)
- GTBP 0.26
- STRR 0.09
- MACD
- GTBP 0.07
- STRR -0.02
- Stochastic Oscillator
- GTBP 96.72
- STRR 0.00
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.